HUP9900804A3 - Use of derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity and new compounds - Google Patents
Use of derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity and new compoundsInfo
- Publication number
- HUP9900804A3 HUP9900804A3 HU9900804A HUP9900804A HUP9900804A3 HU P9900804 A3 HUP9900804 A3 HU P9900804A3 HU 9900804 A HU9900804 A HU 9900804A HU P9900804 A HUP9900804 A HU P9900804A HU P9900804 A3 HUP9900804 A3 HU P9900804A3
- Authority
- HU
- Hungary
- Prior art keywords
- phenoxymethyl
- tetrazole
- derivatives
- acetic acid
- antitumor activity
- Prior art date
Links
- OKACIACGQZSZRA-UHFFFAOYSA-N 5-(phenoxymethyl)-2h-tetrazole Chemical compound N1=NNN=C1COC1=CC=CC=C1 OKACIACGQZSZRA-UHFFFAOYSA-N 0.000 title 1
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/62—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by hydrogenation of carbon-to-carbon double or triple bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
- C07C45/72—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
- C07C45/74—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups combined with dehydration
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/83—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/82—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
- C07C49/835—Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups having unsaturation outside an aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98105726A EP0947511A1 (en) | 1998-03-30 | 1998-03-30 | Derivatives of phenoxy acetic acid and of phenoxymethyl tetrazole having antitumor activity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HU9900804D0 HU9900804D0 (en) | 1999-05-28 |
| HUP9900804A2 HUP9900804A2 (hu) | 1999-11-29 |
| HUP9900804A3 true HUP9900804A3 (en) | 2001-08-28 |
Family
ID=8231677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9900804A HUP9900804A3 (en) | 1998-03-30 | 1999-03-29 | Use of derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity and new compounds |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0947511A1 (hu) |
| JP (1) | JP2000063340A (hu) |
| KR (1) | KR19990078366A (hu) |
| CN (1) | CN1232028A (hu) |
| AR (1) | AR018170A1 (hu) |
| AU (1) | AU2250299A (hu) |
| BR (1) | BR9901208A (hu) |
| CA (1) | CA2267047A1 (hu) |
| HR (1) | HRP990093A2 (hu) |
| HU (1) | HUP9900804A3 (hu) |
| ID (1) | ID22335A (hu) |
| IL (1) | IL129191A0 (hu) |
| MA (1) | MA26616A1 (hu) |
| NO (1) | NO991526L (hu) |
| NZ (1) | NZ334874A (hu) |
| PE (1) | PE20000341A1 (hu) |
| PL (1) | PL332273A1 (hu) |
| SG (1) | SG81972A1 (hu) |
| TR (1) | TR199900719A2 (hu) |
| ZA (1) | ZA992407B (hu) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2841784B1 (fr) * | 2002-07-08 | 2007-03-02 | Composition a base de derives de 1,3-diphenylprop-2en-1-one substitues, preparation et utilisations | |
| FR2841900B1 (fr) | 2002-07-08 | 2007-03-02 | Genfit S A | Nouveaux derives de 1,3-diphenylprop-2-en-1-one substitues, preparation et utilisations |
| FR2857361B1 (fr) * | 2003-07-08 | 2005-09-09 | Genfit S A | PREPARATION DE DERIVES DE 1,3-DIPHENYPROP-2-¼n-1-one |
| WO2005063774A1 (en) * | 2003-12-22 | 2005-07-14 | Johns Hopkins University | Boronic acid aryl analogs |
| JP2007297283A (ja) * | 2004-07-28 | 2007-11-15 | Santen Pharmaceut Co Ltd | 新規桂皮酸関連化合物 |
| SG174107A1 (en) * | 2006-08-30 | 2011-09-29 | Univ Michigan | New small molecule inhibitors of mdm2 and the uses thereof |
| DE602007006519D1 (de) | 2006-09-21 | 2010-06-24 | Hoffmann La Roche | Oxindolderivate als antikrebsmittel |
| US7638548B2 (en) | 2006-11-09 | 2009-12-29 | Hoffmann-La Roche Inc. | Spiroindolinone derivatives |
| US7553833B2 (en) | 2007-05-17 | 2009-06-30 | Hoffmann-La Roche Inc. | 3,3-spiroindolinone derivatives |
| US7928233B2 (en) | 2009-02-10 | 2011-04-19 | Hoffmann-La Roche Inc. | Spiroindolinone pyridine derivatives |
| US8217051B2 (en) | 2009-02-17 | 2012-07-10 | Hoffmann-La Roche Inc. | Spiroindolinone derivatives |
| US8076482B2 (en) | 2009-04-23 | 2011-12-13 | Hoffmann-La Roche Inc. | 3,3′-spiroindolinone derivatives |
| US8017607B2 (en) | 2009-10-14 | 2011-09-13 | Hoffmann-La Roche Inc. | N-substituted-pyrrolidines as inhibitors of MDM2-P-53 interactions |
| US8088815B2 (en) | 2009-12-02 | 2012-01-03 | Hoffman-La Roche Inc. | Spiroindolinone pyrrolidines |
| US8288431B2 (en) | 2010-02-17 | 2012-10-16 | Hoffmann-La Roche Inc. | Substituted spiroindolinones |
| US8217044B2 (en) | 2010-04-28 | 2012-07-10 | Hoffmann-La Roche Inc. | Spiroindolinone pyrrolidines |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3255241A (en) * | 1961-01-19 | 1966-06-07 | Merck & Co Inc | (2-alkylidene acyl)phenoxy-and (2-alkylidene acyl)phenylmercaptocarboxylic acids |
| BE639727A (hu) * | 1962-11-13 | |||
| US3251064A (en) * | 1962-11-13 | 1966-05-10 | Everett M Schultz | beta-aminoacylphenoxy-and beta-aminoacylphenylmercapto-derivatives of monocarboxylicacids |
| US3994955A (en) * | 1975-01-20 | 1976-11-30 | G. D. Searle & Co. | Substituted phenoxydialkylacetic acids and esters |
| US4904697A (en) * | 1987-04-09 | 1990-02-27 | Merrell Dow Pharmaceuticals Inc. | Controlling the growth of certain tumor tissue with chalcone derivatives |
| JPH0624975A (ja) * | 1992-05-12 | 1994-02-01 | Dainippon Ink & Chem Inc | 制癌活性増強剤 |
| DE4327365A1 (de) * | 1993-08-14 | 1995-02-16 | Boehringer Mannheim Gmbh | Verwendung von Phenolen und Phenolderivaten als Arzneimittel mit fibrinogensenkender Wirkung |
-
1998
- 1998-03-30 EP EP98105726A patent/EP0947511A1/en not_active Withdrawn
-
1999
- 1999-03-26 PE PE1999000244A patent/PE20000341A1/es not_active Application Discontinuation
- 1999-03-26 TR TR1999/00719A patent/TR199900719A2/xx unknown
- 1999-03-26 CA CA002267047A patent/CA2267047A1/en not_active Abandoned
- 1999-03-26 ID IDP990274D patent/ID22335A/id unknown
- 1999-03-26 NZ NZ334874A patent/NZ334874A/xx unknown
- 1999-03-26 IL IL12919199A patent/IL129191A0/xx unknown
- 1999-03-26 AR ARP990101366A patent/AR018170A1/es unknown
- 1999-03-26 MA MA25510A patent/MA26616A1/fr unknown
- 1999-03-27 SG SG9901555A patent/SG81972A1/en unknown
- 1999-03-29 NO NO991526A patent/NO991526L/no not_active Application Discontinuation
- 1999-03-29 KR KR1019990010823A patent/KR19990078366A/ko not_active Application Discontinuation
- 1999-03-29 PL PL99332273A patent/PL332273A1/xx unknown
- 1999-03-29 HR HR98105726.8A patent/HRP990093A2/hr not_active Application Discontinuation
- 1999-03-29 ZA ZA9902407A patent/ZA992407B/xx unknown
- 1999-03-29 HU HU9900804A patent/HUP9900804A3/hu unknown
- 1999-03-29 BR BR9901208-1A patent/BR9901208A/pt not_active Application Discontinuation
- 1999-03-30 JP JP11087932A patent/JP2000063340A/ja active Pending
- 1999-03-30 AU AU22502/99A patent/AU2250299A/en not_active Abandoned
- 1999-03-30 CN CN99104509A patent/CN1232028A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR9901208A (pt) | 2000-04-25 |
| PE20000341A1 (es) | 2000-05-08 |
| TR199900719A2 (xx) | 1999-10-21 |
| ID22335A (id) | 1999-09-30 |
| JP2000063340A (ja) | 2000-02-29 |
| SG81972A1 (en) | 2001-07-24 |
| CA2267047A1 (en) | 1999-09-30 |
| AR018170A1 (es) | 2001-10-31 |
| CN1232028A (zh) | 1999-10-20 |
| IL129191A0 (en) | 2000-02-17 |
| NO991526D0 (no) | 1999-03-29 |
| KR19990078366A (ko) | 1999-10-25 |
| AU2250299A (en) | 1999-10-14 |
| HUP9900804A2 (hu) | 1999-11-29 |
| EP0947511A1 (en) | 1999-10-06 |
| ZA992407B (en) | 1999-09-30 |
| PL332273A1 (en) | 1999-10-11 |
| HU9900804D0 (en) | 1999-05-28 |
| NZ334874A (en) | 2000-08-25 |
| HRP990093A2 (en) | 2000-02-29 |
| MA26616A1 (fr) | 2004-12-20 |
| NO991526L (no) | 1999-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9900804A3 (en) | Use of derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity and new compounds | |
| NZ514041A (en) | Dimeric compounds and as inhibitors of neuraminidase | |
| HUP0202477A3 (en) | Use of phthalazine derivatives | |
| PL335027A1 (en) | Derivatives of arylsulphonylamino hydroxamic acid | |
| HUP0002224A3 (en) | Benzimidazole derivatives of antivirus activity | |
| HK1047283A1 (zh) | 以四羥基喹啉葎基(tetrahydroquinolinyl)、芳基或雜芳基和烷基取代的具有視網膜樣的生物活性的胺類 | |
| AU7710300A (en) | Methods for diagnosis and therapy of hematological and virus-associated malignancies | |
| HU9701299D0 (en) | Insuline derivatives of enhanced zinc-binding activity | |
| ZA957188B (en) | Use of 5-substituted pyridine- and hexahydroquinoline-3-carboxylic acid derivatives | |
| ZA957187B (en) | Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments | |
| AU5668499A (en) | Veneer tape and method of use | |
| PL340461A1 (en) | Derivatives of isothiazocarboxylic acid | |
| HK1044536A1 (en) | Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics | |
| PL352200A1 (en) | Inhibitors of viia agent | |
| IL133578A0 (en) | Aryl carboxylic acid and tetrazole derivatives | |
| HU9800373D0 (en) | Steroide compounds of anticeptive and antiosteoporosive activity | |
| AU3256499A (en) | Use of a compound inhibiting the activity of a sodium channel and a calcium channel in a composition for topical use | |
| PL356092A1 (en) | Heteroatom-interrupted analogs of 15-hydroxyeicosatetraenoic acid and methods of use | |
| HUP9802716A3 (en) | Pharmaceutical composition of analgesic activity | |
| IL144662A0 (en) | Use of cholesterol-lowering agent | |
| PL335601A1 (en) | Derivatives of 2-substituted benzoylcycloalkyl carboxylic acid | |
| AU7654200A (en) | Phthalazinone derivatives as pd3/4 inhibitors | |
| AU7653600A (en) | Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis | |
| HUP0102073A3 (en) | Hydroxamic and carboxylic acid derivatives and medicaments containing them | |
| PL354481A1 (en) | Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 |